Here’s an excerpt from this blog by Pillsbury’s Peter Gillon and Alexander Hardiman: Recently, we have seen insurers assert the price change exclusion as a potential defense to coverage at the most critical moment: just when the litigants are seeking to settle shareholders’ breach of fiduciary duty claims against the directors and officers. [read post]